Skip to content

Kontron Cardiovascular

Country not established

Devices
1

What Kontron Cardiovascular makes

Kontron Cardiovascular manufactures the Kontron Cutaneous PCO₂ Monitor, a device designed for continuous, non-invasive monitoring of transcutaneous partial pressure of carbon dioxide (PCO₂) in patients. This tool is intended for use in critical care settings to assess respiratory function and metabolic status by measuring PCO₂ levels through the skin.

The company’s portfolio is regulated under Class II devices in the United States, with the Kontron Cutaneous PCO₂ Monitor listed under a Premarket Approval (PMA) application with the FDA. The device is intended for commercial distribution within the US market.

AI-generated from registry data, 18 Sep 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

Frequently asked questions

How many devices does Kontron Cardiovascular have in the registry?

The registry currently lists 1 device for Kontron Cardiovascular. Devices recorded under merged duplicate company entries are counted once.

Which registries list Kontron Cardiovascular's devices?

Among its 1 most recently registered device, Kontron Cardiovascular has devices listed in FDA PMA (1 device).

What risk classes do Kontron Cardiovascular's devices fall under?

Among its 1 most recently registered device, the classes recorded for Kontron Cardiovascular's devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Kontron Cardiovascular in the registry?

The most recently registered devices listed for Kontron Cardiovascular include KONTRON CUTANEOUS PCO2 MONITOR.

Generated automatically from registry data and not verified by a human reviewer.